脂肪甘油三酯脂肪酶 (ATGL) 限制了细胞甘油三酯库中脂肪酸的动员速度。由于脂肪酸代谢失调与血脂异常和代谢紊乱密切相关,因此 ATGL 是令人感兴趣的药理学靶点。我们在此报告了 ATGL 小分子抑制剂的开发和特性。Atglistatin 对 ATGL 具有选择性,可在体外和体内减少脂肪酸动员。ATGL 执行三酰甘油 (TG) 分解代谢的第一步,生成二酰甘油,随后被激素敏感性脂肪酶 (HSL) 和单酰甘油脂肪酶 (MGL) 降解为甘油和脂肪酸 (FA)。
脂肪甘油三酯脂肪酶 (ATGL) 和激素敏感性脂肪酶 (HSL) 是在体外测定和小鼠白色脂肪组织 (WAT) 器官培养中导致三酰甘油 (TG) 分解的主要酶。
Adipose triglyceride lipase (ATGL) is rate-limiting in the mobilization of fatty acids from cellular triglyceride stores. This central role in lipolysis marks ATGL as interesting pharmacological target since deregulated fatty acid metabolism is closely linked to dyslipidemic and metabolic disorders. Here we report on the development and characterization of a small-molecule inhibitor of ATGL. Atglistatin is selective for ATGL and reduces fatty acid mobilization in vitro and in vivo. ATGL performs the first step in triacylglycerol (TG) catabolism generating diacylglycerol which is subsequently degraded by hormone-sensitive lipase (HSL) and monoglyceride lipase (MGL) into glycerol and fatty acids (FA).
Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) are the major enzymes contributing to triacylglycerol (TG) breakdown in in vitro assays and in organ cultures of murine white adipose tissue (WAT).
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号